Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CCR2 Targeted Molecular Imaging and Treatment of Abdominal Aortic Aneurysms

NCT04586452 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04586452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04586452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CCR2 Targeted Molecular Imaging and Treatment of Abdominal Aortic Aneurysms
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
February 17, 2021
Completion date
April 4, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm (aaa), no abdominal aortic aneurysm (non-aaa)